Core Scientific (CORZ) Insider Todd Duchene Sells $282K of Stock

On June 15, 2026, Todd Duchene, an insider at Core Scientific, Inc. (NasdaqGS: CORZ), sold 10,000 shares of the company. The shares were sold at an average price of $28.20 each, totaling approximately $281,960. This transaction was part of a planned sale.

Insider Buying and Selling at Core Scientific, Inc.

Todd Duchene has been active in selling Core Scientific shares recently. Prior to the June 15 transaction, he sold another 10,000 shares on June 8 at $26.85 per share, and on June 1 at $28.37 per share. Additionally, on May 26, he sold 10,000 shares at $26.25. However, Duchene also acquired 138,547 shares on May 20. Another insider, Stephen Smith, purchased 18,961 shares on May 26.

Other Institutional Activity in Core Scientific

Several institutional investors have adjusted their positions in Core Scientific. Situational Awareness Partners LP increased its holdings by 26,008,473 shares, now holding shares valued at approximately $389.1 million. UBS Group AG also raised its stake by 5,716,683 shares, bringing its total to 25,533,940 shares valued around $382 million. Conversely, Situational Awareness LP reduced its position by 2,748,005 shares, now holding 26,008,473 shares worth about $389.1 million. Pentwater Capital Management LP and BlackRock, Inc. also trimmed their holdings slightly.

Core Scientific, Inc. Stock Up 107.8%

Shares of Core Scientific were trading at $28.08. The company has a market cap of roughly $8.93 billion and a forward P/E ratio of 94.65, indicating high expectations for future earnings. The stock's beta is 5.484, showing significant volatility. It has traded between $10.93 and $30.46 over the past year, with a 50-day moving average of $23.25 and a 200-day moving average of $18.57.

Recent Earnings

Core Scientific reported revenue of $354.7 million, with a growth rate of 44.9%. Despite this, the company is not currently profitable, as reflected in its negative earnings per share (EPS) of -$3.36. The next earnings report is expected on August 7, 2026.

Analysts Set New Price Targets

Analysts have been active in updating their views on Core Scientific. On June 16, 2026, Freedom Broker initiated coverage with a 'hold' rating and a $33 price target. B. Riley Securities and Jefferies maintained their 'buy' ratings with targets of $33 and $37, respectively. The consensus among 16 analysts remains a 'strong buy' with a mean price target of $32.55.

About Core Scientific, Inc.

Core Scientific, Inc. offers infrastructure services for high-density colocation and digital asset mining in the U.S. The company operates through segments focused on colocation, self-mining, and hosted mining. It provides services such as space, power, and cooling for machine learning and AI workloads, as well as digital asset mining operations. Founded in 2017, Core Scientific is headquartered in Dover, Delaware, and led by CEO Adam Sullivan.

Bottom Line

Todd Duchene's planned sale of Core Scientific shares is a notable insider activity. Investors often watch insider transactions for potential signals about a company's prospects. Core Scientific continues to attract interest with its substantial market cap and analyst support, though its high forward P/E and lack of profitability may give some investors pause. As always, remember that insider sales are planned and may not reflect immediate changes in company outlook.